Advertisement

Diagnosis of Etiology in Acute Pancreatitis

  • Nicolò de Pretis
  • Luca FrulloniEmail author
Chapter
  • 151 Downloads

Abstract

The correct identification of etiology in patients with acute pancreatitis is crucial for the outcome of the patient in clinical practice. Biliary acute pancreatitis is the predominant form of the disease, and it is characterized by a transient elevation of transaminases. Other etiologies, such as alcohol consumption, hypertriglyceridemia, drugs, parenchymal, and ductal abnormalities/lesions, need to be excluded in patients with normal transminases before considering the acute pancreatitis as idiopathic. Genetic testing may be considered in selected patients. The aim of the present chapter is to propose a bedside algorithm for clinical practice.

Keywords

Acute pancreatitis Etiology Gallstone pancreatitis Diagnostic algorithm 

References

  1. 1.
    Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179–87.CrossRefGoogle Scholar
  2. 2.
    Forsmarkk CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–44.CrossRefGoogle Scholar
  3. 3.
    Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol. 1994;89:1863–6.PubMedGoogle Scholar
  4. 4.
    De Lèdinghen V, Lecesne R, Raymond JM, Gense V, Amouretti M, Drouillard J, et al. Diagnosis of choledicholithiasis: EUS or magnetic resonance cholangiography? A prospective controller study. Gatrointest Endosc. 1999;49:26–31.CrossRefGoogle Scholar
  5. 5.
    Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008;168:649–56.CrossRefGoogle Scholar
  6. 6.
    Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine. 2015;2:1996–2002.CrossRefGoogle Scholar
  7. 7.
    Setiawan VW, Monroe K, Lugea A, Yadav D, Pandol S. Uniting epidemiology and experimental disease models for alcohol-related pancreatic disease. Alcohol Res. 2017;38:173–82.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48:195–203.CrossRefGoogle Scholar
  9. 9.
    de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 2018;6:649–55.CrossRefGoogle Scholar
  10. 10.
    Carr RA, Rejowski BJ, Cote GA, Pitt HA, Zyromski NJ. Systematic review of hypetriglyceridemia-induced acute pancreatitis: a more virulent etiology? Pancreatology. 2016;16:469–76.CrossRefGoogle Scholar
  11. 11.
    Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.CrossRefGoogle Scholar
  12. 12.
    Buelow R, Simon P, Thiel R, Thamm P, Messner P, Lerch MM, et al. Anatomic variants of the pancreatic duct and their clinical relevance: an MR-guided study in the general population. Eur Radiol. 2014;24:3142–9.CrossRefGoogle Scholar
  13. 13.
    Manfredi R, Pozzi Mucelli R. Secretin-enhanced MR imaging of the pancreas. Radiology. 2016;279:29–43.CrossRefGoogle Scholar
  14. 14.
    Tenner S. Drug induced acute pancreatitis: does it exist? World J Gastroenterol. 2014;20:16529–34.CrossRefGoogle Scholar
  15. 15.
    Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroentreol Hepatol. 2007;5:648–61.CrossRefGoogle Scholar
  16. 16.
    Whitcomb DC. Genetic aspects of pancretitis. Annu Rev Med. 2010;61:413–24.CrossRefGoogle Scholar
  17. 17.
    DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroentreol. 2005;21:544–54.CrossRefGoogle Scholar
  18. 18.
    Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet. 2003;67:471–85.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of MedicinePancreas Institute, University of VeronaVeronaItaly

Personalised recommendations